NanoTalks by Curapath is your gateway to the future of healthcare nanotechnology. In each episode, we explore the latest trends in lipid and polymer nanoparticles a groundbreaking field transforming how next-generation therapies and vaccines are developed. Discover how these tiny, multifunctional structures can enhance treatment effectiveness, minimize side effects, and open the door to innovations that once seemed out of reach. Join us as we delve into cutting-edge research, clinical insights, and the major advances shaping modern medicine
Hot topics
NanoTalks
When Does a Polymer Need to Be GMP Grade?
Understand when a polymer truly needs to be GMP grade and how to select the right quality strategy for your application.
This article explores how polymer quality requirements vary depending on their intended use, from pharmaceutical excipients and drug delivery systems to medical devices, ancillary materials and manufacturing reagents. It explains the differences between research-grade, enhanced quality and GMP-grade polymers, examines the regulatory and risk-based factors that influence material selection, and provides practical guidance to help developers balance compliance, traceability, scalability and cost throughout the product development lifecycle.
.jpg?width=1603&height=1080&name=fotos%20blog%20(1).jpg)
Keep exploring Curapath Blog , there is more NanoTalks yet to explore
Recent Articles
- Filter by:
- All
- LNP
- Polymers
- Analytics
- Regulatory
.png)
Polymers play a wide variety of rolesin today´s pharmaceutical landscape. They are used as excipients, drug delivery...
-1.jpg)
In polymer–drug conjugates, the polymer is not only a passive carrier. Its chemistry, molecular weight, architecture,...
.png)
Active targeting has emerged as one of the most promising strategies to unlock extrahepatic delivery of nanoparticles,...
.png)
The outcome of this step directly defines critical quality attributes, including: Particle size Polydispersity index...
.png)
Polymeric excipients play a critical role in modern therapeutic systems being a fundamental partin advanced and highly...
.png)
Medical device–associated infections remain a major challenge across healthcare, especially for catheters, orthopedic...
.jpg)
Polymer–drug conjugates (PDCs) represents a unique strategy in modern drug delivery: instead of encapsulating a drug...
Lipid–polymer hybrid nanoparticles (LPHNs) are emerging as one of the most promising platforms in nanomedicine....
.png)
Transfection, the process of introducing nucleic acids into cells, is a cornerstone of modern biotechnology, enabling...
.png)
Functionalized polymers are revolutionizing pharmaceutical science by bridging chemistry and biology in ways that...
.png)
Replacing PEG in lipid nanoparticles (LNPs) marks a critical evolution in the development of safer and more effective...
.png)
Over the past 20 years, polymer-based drug delivery systems have evolved from experimental platforms to clinically...
.jpg)
Messenger RNA (mRNA) technology surged into the global spotlight during the COVID-19 pandemic, showcasing its power to...
Early-stage research frequently takes center stage in the fields of biopharmaceuticals and the development of advanced...
.jpg)
Sterile filtration and aseptic fill & finish are essential components in gene therapy manufacturing, critical for...
Nanoparticle-based drug delivery has revolutionized how therapeutics can be transported and released within the human...
Process Performance Qualification (PPQ) is a critical part of the pharmaceutical manufacturing validation lifecycle,...
Currently, lipid nanoparticles (LNPs) stand as the predominant delivery system for emerging mRNA-based therapeutic...
RNA‑based therapeutics have rapidly evolved from niche research tools to transformative medicines, powering...
Peptide therapeutics offer high specificity and strong safety profiles, but their effectiveness depends on overcoming...